Zhihao Meng

Use of comedications and potential drug-drug interactions in people living with HIV in China.

Hongzhou Lu, Yinzhong Shen, Jun Chen, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Report of a COVID-19 Case Combined with HIV Infection

Yuanlong Xu, Guowei Wu, Aimei Liu, 2020 .

Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy

C. Ning, Hao Liang, Hong Zhang, 2021, BMC Infectious Diseases.

Predictive Factors of High-Risk Events for Virological Failure in HIV/AIDS Patients Receiving Long-Term Antiviral Therapy

C. Ning, Hao Liang, Hong Zhang, 2021 .

Anemia and opportunistic infections in hospitalized people living with HIV: a retrospective study

Zhihao Meng, Yanling Hu, Ke Lan, 2022, BMC Infectious Diseases.

Immune characteristics of human immunodeficiency virus/severe acute respiratory syndrome coronavirus 2 coinfection: A case report and mini-review

Yuanlong Xu, Guowei Wu, Aimei Liu, 2021, SAGE open medical case reports.

Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China

H. Chen, Hongzhou Lu, W. Xia, 2017, Scientific Reports.

Patient-Reported Noninfectious Comorbidities in Chinese HIV-Infected Patients: The Gaps Among Self-Awareness, Diagnosis, and Prevalence

Hongzhou Lu, Haibo Ding, Yaokai Chen, 2021 .

Prediction of the risk of cytopenia in hospitalized HIV/AIDS patients using machine learning methods based on electronic medical records

Kai Zhang, Yuanlong Xu, J. Qin, 2023, Frontiers in public health.

The association between serum CD4 T lymphocyte counts and surgical outcomes in HIV/AIDS patients in Guangxi, China: a retrospective cohort study

Lin Liao, Minfu He, Cunxu Liu, 2021, PeerJ.

High baseline body mass index predicts recovery of CD4+ T lymphocytes for HIV/AIDS patients receiving long-term antiviral therapy

C. Ning, Weiyi Tian, Li Jiang, 2022, PloS one.